Iridia

Carlsbad, United States

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

$6.0M raised

Nov 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Iridia raised?

Iridia has raised $6.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are Iridia's investors?

Iridia's investors include Prime Movers Lab, LifeSci Venture Partners, Longley Capital, TCA Venture Group, ATEM Capital Fund LP.

Where is Iridia headquartered?

Iridia is headquartered in Carlsbad, United States.

What does Iridia do?

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

What stage is Iridia at?

Iridia is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 15, 2021.

MLA

"Iridia — Funding & Investors." VCBacked, November 15, 2021, https://www.vcbacked.co/company/iridia. Accessed July 2, 2026.

APA

VCBacked. (2021). Iridia — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/iridia

Wikipedia (cite web)

{{cite web |title=Iridia — Funding & Investors |url=https://www.vcbacked.co/company/iridia |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 15, 2021.